PRME FY 2021 Earnings — Prime Medicine, Inc. Revenue & Financial Results | Market Cap Arena

PRMEPrime Medicine, Inc.

$771M

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

$0

Operating Income

-$84M

Net Income

-$165M

EPS (Diluted)

$-1.92

Cash Flow

Operating Cash Flow

-$34M

Free Cash Flow

-$38M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$302M

Total Liabilities

$62M

Stockholders' Equity

$240M

Cash & Equivalents

$185M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$5M	-100.0%
Gross Profit	$0	$2M	-100.0%
Operating Income	-$84M	-$932,000	-8963.7%
Net Income	-$165M	-$3M	-4749.5%